The most dismal numbers often yield the best decisions in matters of life and death US President Donald Trump has touted hydroxychloroquine as a game-changer against covid-19.
On Saturday, he urged Prime Minister Narendra Modi to let US orders placed with Indian drugmakers be sent off. The request came on a day India withdrew all exemptions granted under its 25 March export ban on the drug.
Our aim of local supply sufficiency, however, could well constrain us to say no. The anti-malaria pill, which is also used for lupus and rheumatoid arthritis, has not passed clinical trials yet to fight covid-19.
But doctors across Europe, China and Korea, even in India, are reported to have found it useful for covid-19 patients. It seems to suppress
Read more on livemint.com